Treating the older patient with leukemia, lymphoma, and myeloma.
This program focused on the challenges of treating older adults with leukemia, lymphoma, and myeloma; how older adults can be assessed to anticipate any age-related barriers to therapy; and how emerging therapies and better side effect management offer older adults access to promising outcomes not possible years ago.